(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

LANREOSCAN

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

LANREOSCAN

ST13

US500000086673026

Classe

5

Pedido

86673026

Registro

6098450

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

93

Atualização mais recente

03/09/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5

Data de depósito

24/06/2015

Data de registro

14/07/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

14/07/2020

Última transação

03/09/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Código do desenho

4

Tipo de titular

99

Localização do titular

Paris, FR

Examinador

HILLIARD, JESSICA

Unidade examinadora

N20

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Ipsen Pharma S.A.S.
Ipsen Pharma S.A.S.

Representantes

Ben Natter HAUG PARTNERS, LLP

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparationspharmaceutical preparations for use in the treatment of oncological diseases; pharmaceutical preparations for the treatment or identification of cancer cells in humans; pharmaceutical preparations for use in the treatment of neurological diseases; pharmaceutical preparations for use in the treatment of endocrine disorders; pharmaceutical preparations for use in the treatment of urological diseases; pharmaceutical preparations for use in the treatment of hormonal disorders; pharmaceutical preparations for the treatment of gastrointestinal bleeding disorders; and pharmaceutical preparations for use in treatment of blood diseases

Publicações

Histórico de despachos e eventos da marca no USPTO.

93 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

28/08/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

28/08/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

28/08/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

28/08/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

28/08/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

14/07/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

23/08/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

23/08/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

23/08/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

23/08/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

14/01/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

14/01/2022

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

14/01/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

14/01/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

14/01/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

14/01/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/01/2022

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

06/01/2022

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

06/01/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/01/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/01/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

30/12/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

30/12/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

30/12/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

30/12/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

30/12/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

14/07/2020

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

10/06/2020

IUCN

NOTICE OF ALLOWANCE CANCELLED

03/06/2020

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

03/06/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/03/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/03/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/03/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/03/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/03/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/03/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

19/11/2019

EX5G

SOU EXTENSION 5 GRANTED

18/11/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

18/11/2019

EXT5

SOU EXTENSION 5 FILED

13/11/2019

EEXT

SOU TEAS EXTENSION RECEIVED

13/11/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/08/2019

EX4G

SOU EXTENSION 4 GRANTED

01/08/2019

EXT4

SOU EXTENSION 4 FILED

01/08/2019

EEXT

SOU TEAS EXTENSION RECEIVED

01/08/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

19/02/2019

EX3G

SOU EXTENSION 3 GRANTED

15/02/2019

EXT3

SOU EXTENSION 3 FILED

15/02/2019

EEXT

SOU TEAS EXTENSION RECEIVED

15/02/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

13/07/2018

EX2G

SOU EXTENSION 2 GRANTED

11/07/2018

EXT2

SOU EXTENSION 2 FILED

11/07/2018

EEXT

SOU TEAS EXTENSION RECEIVED

11/07/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

21/02/2018

EX1G

SOU EXTENSION 1 GRANTED

19/02/2018

EXT1

SOU EXTENSION 1 FILED

19/02/2018

EEXT

SOU TEAS EXTENSION RECEIVED

19/02/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

22/08/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

27/06/2017

PUBO

PUBLISHED FOR OPPOSITION

27/06/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/06/2017

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

22/05/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/05/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/05/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/05/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

27/04/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

27/04/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/11/2016

GNRT

NON-FINAL ACTION E-MAILED

03/11/2016

CNRT

NON-FINAL ACTION WRITTEN

03/11/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

13/10/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

13/10/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/10/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

29/09/2016

GNRT

NON-FINAL ACTION E-MAILED

29/09/2016

CNRT

NON-FINAL ACTION WRITTEN

29/09/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/09/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/09/2016

ALIE

ASSIGNED TO LIE

01/09/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

24/08/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

25/02/2016

GNRT

NON-FINAL ACTION E-MAILED

25/02/2016

CNRT

NON-FINAL ACTION WRITTEN

25/02/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/02/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/02/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/02/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/08/2015

GNRT

NON-FINAL ACTION E-MAILED

07/08/2015

CNRT

NON-FINAL ACTION WRITTEN

07/08/2015

DOCK

ASSIGNED TO EXAMINER

05/08/2015

DOCK

ASSIGNED TO EXAMINER

01/08/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/07/2015

NWAP

NEW APPLICATION ENTERED

27/06/2015

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace LANREOSCAN ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.